Introduced Version SENATE BILL No. 99 _____ DIGEST OF INTRODUCED BILL Citations Affected: IC 2-5-41.1; IC 6-2.5-5-58; IC 6-7; IC 7.1-8; IC 7.1-9; IC 9-30; IC 35-38-9-1.5; IC 35-46-9-6; IC 35-48-4. Synopsis: Cannabis regulation. Permits the use of cannabis by: (1) a person at least 21 years of age; and (2) a person with a serious medical condition as determined by the person's physician. Establishes the adult use cannabis excise tax, and requires a retailer to transfer the tax to the department of state revenue for deposit in the state general fund. Exempts veterans from payment of the sales tax on medical or adult use cannabis. Establishes a cannabis program (program) to permit the cultivation, processing, testing, transportation, and sale of cannabis by holders of a valid permit. Establishes the Indiana cannabis commission (ICC) as a state agency to oversee, implement, and enforce the program, and establishes the ICC advisory committee to review the effectiveness of the program. Requires that permit holders take steps to prevent diversion of cannabis to unauthorized persons. Requires that cannabis and cannabis products be properly labeled, placed in child resistant packaging, and tested by an independent testing laboratory before being made available for purchase. Prohibits packaging cannabis in a manner that is appealing to children. Authorizes research on cannabis in accordance with rules set forth by the ICC. Establishes a procedure for the expungement of a cannabis related conviction if the act constituting the conviction becomes legal. Makes conforming amendments. Effective: July 1, 2024. Pol Jr. January 8, 2024, read first time and referred to Committee on Commerce and Technology. 2024 IN 99—LS 6236/DI 106 Introduced Second Regular Session of the 123rd General Assembly (2024) PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in this style type. Additions: Whenever a new statutory provision is being enacted (or a new constitutional provision adopted), the text of the new provision will appear in this style type. Also, the word NEW will appear in that style type in the introductory clause of each SECTION that adds a new provision to the Indiana Code or the Indiana Constitution. Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts between statutes enacted by the 2023 Regular Session of the General Assembly. SENATE BILL No. 99 A BILL FOR AN ACT to amend the Indiana Code concerning criminal law and procedure. Be it enacted by the General Assembly of the State of Indiana: 1 SECTION 1. IC 2-5-41.1 IS ADDED TO THE INDIANA CODE 2 AS A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE 3 JULY 1, 2024]: 4 Chapter 41.1. ICC Advisory Committee 5 Sec. 1. The following definitions apply throughout this chapter: 6 (1) "Advisory committee" means the ICC advisory committee 7 established by section 2 of this chapter. 8 (2) "ICC" means the Indiana cannabis commission 9 established by IC 7.1-9-2-1. 10 Sec. 2. The ICC advisory committee is established to serve the 11 general assembly as a continuing committee. Except as otherwise 12 provided by this chapter, the advisory committee shall operate 13 under the rules of the legislative council. 14 Sec. 3. (a) The advisory committee consists of the following four 15 (4) voting members and eight (8) nonvoting members: 16 (1) One (1) legislative member, appointed as a voting member 17 by the speaker. 2024 IN 99—LS 6236/DI 106 2 1 (2) One (1) legislative member, appointed as a voting member 2 by the minority leader of the house of representatives. 3 (3) One (1) legislative member, appointed as a voting member 4 by the president pro tempore. 5 (4) One (1) legislative member, appointed as a voting member 6 by the minority leader of the senate. 7 (5) One (1) representative of law enforcement, appointed as a 8 nonvoting member by the speaker. 9 (6) One (1) individual having experience in the treatment of 10 medical conditions by means of cannabis as a patient, 11 physician, or caregiver, appointed as a nonvoting member by 12 the president pro tempore. 13 (7) The commissioner of the department of state revenue or 14 the commissioner's designee, who serves as a nonvoting 15 member. 16 (8) The director of the Indiana state department of 17 agriculture or the director's designee, who serves as a 18 nonvoting member. 19 (9) The state health commissioner or the commissioner's 20 designee, who serves as a nonvoting member. 21 (10) A representative of an Indiana based cannabis trade 22 organization, appointed by the speaker as a nonvoting 23 member. 24 (11) A representative of an experienced manufacturer of low 25 THC hemp extract, appointed by the president pro tempore 26 as a nonvoting member. 27 (12) An experienced hemp grower, appointed by the state seed 28 commissioner as a nonvoting member. 29 (b) The chairperson of the legislative council shall annually 30 select one (1) of the voting members to serve as chairperson of the 31 advisory committee. Whenever there is a new chairperson of the 32 legislative council, that chairperson may select a new voting 33 member to serve as chairperson of the advisory committee. The 34 chairperson of the advisory committee serves at the pleasure of the 35 chairperson of the legislative council. 36 Sec. 4. (a) Except as otherwise provided in this chapter, the term 37 of a member of the advisory committee ends on June 30 of the next 38 odd-numbered year following the member's appointment. 39 However, the member may be reappointed to subsequent terms. 40 (b) A member of the advisory committee may be removed at any 41 time by the appointing authority who appointed the member. 42 (c) If a vacancy exists on the advisory committee, the appointing 2024 IN 99—LS 6236/DI 106 3 1 authority who appointed the former member whose position has 2 become vacant shall appoint an individual to fill the vacancy. An 3 individual appointed to fill a vacancy serves for the remainder of 4 the term of the former member. 5 (d) If a member of the advisory committee ceases to: 6 (1) be a member of the chamber from which the member was 7 appointed; or 8 (2) hold the member's office; 9 the member ceases to be a member of the advisory committee. 10 Sec. 5. Each member of the advisory committee is entitled to 11 receive the same per diem, mileage, and travel allowances paid to 12 individuals who serve as legislative and lay members, respectively, 13 of interim study committees established by the legislative council. 14 Sec. 6. (a) The advisory committee shall meet at the call of the 15 chairperson. 16 (b) Seven (7) members of the advisory committee constitute a 17 quorum if at least three (3) of the members present are voting 18 members. 19 (c) The affirmative vote of a majority of the voting members 20 appointed to the advisory committee is required for the advisory 21 committee to take action on any measure, including final reports. 22 Sec. 7. The advisory committee shall do the following, as 23 applicable: 24 (1) Review rules adopted by the ICC. 25 (2) Review legislative proposals suggested by the ICC. 26 (3) Evaluate the cannabis research and development program 27 under IC 7.1-9-5. 28 (4) Evaluate the operation of the medical and adult use 29 cannabis programs. 30 (5) Consider any other matter that has bearing on the 31 operation of the medical and adult use cannabis programs. 32 Sec. 8. All meetings of the advisory committee are open to the 33 public in accordance with and subject to IC 5-14-1.5. All records 34 of the advisory committee are subject to the requirements of 35 IC 5-14-3. 36 Sec. 9. The legislative services agency shall staff the advisory 37 committee. 38 Sec. 10. All funds necessary to carry out this chapter shall be 39 paid from appropriations to the legislative council and the 40 legislative services agency. 41 SECTION 2. IC 6-2.5-5-58 IS ADDED TO THE INDIANA CODE 42 AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY 2024 IN 99—LS 6236/DI 106 4 1 1, 2024]: Sec. 58. Transactions involving medical cannabis (as 2 defined in IC 7.1-8-1-1) and adult use cannabis (as defined in 3 IC 7.1-8-1-1) are exempt from the state gross retail tax if the 4 person acquiring the cannabis is a veteran (as defined in 5 IC 23-14-54.5-5). 6 SECTION 3. IC 6-7-3 IS REPEALED [EFFECTIVE JULY 1, 2024]. 7 (Controlled Substance Excise Tax). 8 SECTION 4. IC 6-7-5 IS ADDED TO THE INDIANA CODE AS 9 A NEW CHAPTER TO READ AS FOLLOWS [EFFECTIVE JULY 10 1, 2024]: 11 Chapter 5. Adult Use Cannabis Excise Tax 12 Sec. 1. The following definitions apply throughout this chapter: 13 (1) "Adult use cannabis" has the meaning set forth in 14 IC 7.1-8-1-1. 15 (2) "Department" means the department of state revenue. 16 (3) "Medical cannabis" has the meaning set forth in 17 IC 7.1-8-1-1. 18 (4) "Qualified retailer" has the meaning set forth in 19 IC 7.1-8-1-1. 20 Sec. 2. The adult use cannabis excise tax is imposed on adult use 21 cannabis sold in Indiana. The adult use cannabis excise tax is not 22 imposed on medical cannabis. 23 Sec. 3. The adult use cannabis excise tax is: 24 (1) one percent (1%) of the gross retail income received by the 25 qualified retailer for the purchase of adult use cannabis, 26 during the state fiscal year beginning July 1, 2024; 27 (2) two percent (2%) of the gross retail income received by the 28 qualified retailer for the purchase of adult use cannabis, 29 during the state fiscal year beginning July 1, 2025; and 30 (3) three percent (3%) of the gross retail income received by 31 the qualified retailer for the purchase of adult use cannabis, 32 during and after the state fiscal year beginning July 1, 2026. 33 Sec. 4. A qualified retailer shall collect the adult use cannabis 34 excise tax at the time the adult use cannabis is dispensed. 35 Sec. 5. Before the fifteenth day of each month, each qualified 36 retailer liable for the tax imposed by this chapter shall: 37 (1) file a return with the department that includes all 38 information required by the department, including the: 39 (A) name of the qualified retailer; 40 (B) address of the qualified retailer; 41 (C) invoice date; 42 (D) invoice number; and 2024 IN 99—LS 6236/DI 106 5 1 (E) gross retail income received from the sale of adult use 2 cannabis dispensed during the preceding month; and 3 (2) pay the tax for which it is liable under this chapter for the 4 preceding month, minus the amount specified in section 6 of 5 this chapter. 6 All returns required to be filed and taxes required to be paid under 7 this chapter must be made in an electronic format prescribed by 8 the department. 9 Sec. 6. A qualified retailer that files a complete return and pays 10 the tax due within the time specified in section 5 of this chapter is 11 entitled to deduct and retain from the tax a collection allowance of 12 seven-thousandths (0.007) of the amount due. If a qualified retailer 13 files an incomplete report, the department may reduce the 14 collection allowance by an amount that does not exceed the lesser 15 of: 16 (1) ten percent (10%) of the collection allowance; or 17 (2) fifty dollars ($50). 18 Sec. 7. The department shall deposit the taxes collected under 19 this chapter in the state general fund. 20 SECTION 5. IC 7.1-8 IS ADDED TO THE INDIANA CODE AS A 21 NEW ARTICLE TO READ AS FOLLOWS [EFFECTIVE JULY 1, 22 2024]: 23 ARTICLE 8. CANNABIS 24 Chapter 1. Definitions 25 Sec. 1. The following definitions apply throughout this article: 26 (1) "Adult cannabis user" means a person at least twenty-one 27 (21) years of age who has not been issued a patient or 28 caregiver identification card, unless the patient or caregiver 29 identification card has expired. 30 (2) "Adult use cannabis" means cannabis for use by a person 31 at least twenty-one (21) years of age. 32 (3) "Cannabis" means any part of the plant genus Cannabis. 33 (4) "Cannabis organization" means a qualified retailer, a 34 grower, a processor, or a testing laboratory. 35 (5) "Caregiver" means the individual designated by a patient 36 under this article to obtain, possess, deliver, and assist in the 37 administration of cannabis to the patient. 38 (6) "Certification" means the certification issued to a patient 39 by a physician under this article. 40 (7) "Family or household member" means a person described 41 in IC 35-31.5-2-128. 42 (8) "Form of cannabis" means the characteristics of the 2024 IN 99—LS 6236/DI 106 6 1 cannabis recommended for a particular patient, including the 2 method of consumption, and any particular dosage, strain, 3 variety, quantity, or percentage of cannabis or of a particular 4 active ingredient. 5 (9) "Grower" means a person that holds a permit issued by 6 the ICC to grow cannabis. 7 (10) "ICC" means the Indiana cannabis commission 8 established by IC 7.1-9-2-1. 9 (11) "ICC committee" means the ICC commissioners 10 described in IC 7.1-9-2. 11 (12) "INSPECT" means the Indiana scheduled prescription 12 electronic collection and tracking program established by 13 IC 25-1-13-4. 14 (13) "Medical cannabis" means cannabis for medical use. 15 (14) "Patient" means an individual who: 16 (A) has a serious medical condition; and 17 (B) meets the requirements for certification for the use of 18 cannabis under this article. 19 (15) "Patient or caregiver identification card" means a 20 document issued to a patient or caregiver by the ICC 21 authorizing access to cannabis. 22 (16) "Permit" means an authorization issued by the ICC to a 23 cannabis organization to conduct activities under this article. 24 (17) "Processor" means a person that holds a permit issued by 25 the ICC to process or convert cannabis into a marketable 26 form. 27 (18) "Qualified retailer" means a person that holds a permit 28 issued by the ICC to sell cannabis. 29 (19) "Serious medical condition" means a medical condition 30 for which, in the professional opinion of a physician, the 31 benefits of treatment with cannabis are greater than the risks 32 of treatment with cannabis. 33 (20) "Testing laboratory" means a laboratory that analyzes 34 cannabis. 35 (21) "Transporter" means a person who transports cannabis 36 or paraphernalia. The term includes a person who does not 37 possess a permit or patient or caregiver identification card. 38 Chapter 2. Cannabis Program 39 Sec. 1. (a) The cannabis program is established to serve: 40 (1) patients suffering from a serious medical condition; and 41 (2) adult cannabis users. 42 (b) The ICC shall administer the program. 2024 IN 99—LS 6236/DI 106 7 1 (c) The ICC has regulatory, enforcement, and exporting 2 authority over the growing, processing, sale, transporting, and use 3 of medical and adult use cannabis. The ICC shall contract with the 4 state chemist for the testing and growing of medical and adult use 5 cannabis. 6 Sec. 2. The ICC shall do the following: 7 (1) Issue a permit to a qualifying cannabis organization 8 authorizing it to grow, process, sell, or test cannabis. 9 (2) Establish and maintain an electronic data base to store 10 and track information relating to the cannabis program. The 11 data base must: 12 (A) have the ability to authenticate in real time a patient or 13 caregiver identification card presented to a qualified 14 retailer; 15 (B) track in real time the amount of cannabis provided to: 16 (i) a patient or caregiver; or 17 (ii) an adult cannabis user; 18 at a qualified retailer, share this information in real time 19 with other qualified retailers to prevent diversion, and 20 issue a "stop sale" warning if a purchaser will exceed the 21 allowable amount of cannabis that the purchaser may 22 possess; 23 (C) store records relating to a certification, including, if 24 applicable, the recommended form of cannabis and any 25 early expiration date recommended by the physician; and 26 (D) track the cultivation, processing, transport, storage, 27 and sale of cannabis. 28 (3) Maintain within the ICC's data base an electronic 29 directory of patients and caregivers approved to use or assist 30 in the administration of medical cannabis. 31 (4) Develop enforcement procedures, including announced 32 and unannounced inspections of: 33 (A) a qualified retailer; 34 (B) a grower facility; 35 (C) a processor facility; and 36 (D) all records of a cannabis organization. 37 (5) Establish a program to authorize the use of cannabis for 38 research purposes, and issue documents to permit a 39 researcher to obtain cannabis for research purposes. 40 (6) Establish and maintain public outreach programs about 41 the cannabis program, including: 42 (A) a dedicated telephone number for adult cannabis users, 2024 IN 99—LS 6236/DI 106 8 1 patients, caregivers, and members of the public to obtain 2 basic information about the sale of medical and adult use 3 cannabis; and 4 (B) a publicly accessible website containing information 5 similar to that described in clause (A). 6 (7) Collaborate as necessary with other state agencies, and 7 contract with third parties as necessary to carry out the 8 cannabis program, including public education campaigns 9 regarding the dangers of impaired driving and inappropriate 10 consumption by youth. 11 (8) Develop record keeping requirements for all books and 12 papers, any electronic data base or tracking system data, and 13 other information of a cannabis organization. Information 14 shall be retained for at least four (4) years unless otherwise 15 provided by the ICC. 16 (9) Restrict the advertising and marketing of cannabis, which 17 must be consistent with the federal regulations governing 18 prescription drug advertising and marketing. 19 Sec. 3. The ICC shall adopt rules under IC 4-22-2 to implement 20 this article. 21 Sec. 4. (a) The ICC shall maintain a confidential list of patients 22 and caregivers to whom it has issued patient or caregiver 23 identification cards. Except as provided in subsection (b), all 24 information obtained by the ICC relating to patients, caregivers, 25 and other applicants is confidential. 26 (b) The following records are public: 27 (1) An application for a permit submitted by a cannabis 28 organization. 29 (2) Information relating to penalties or other disciplinary 30 actions taken against a cannabis organization for violation of 31 this article. 32 Chapter 3. Use of Cannabis 33 Sec. 1. Notwithstanding any law to the contrary, the use, 34 possession, delivery, distribution, transport, cultivation, or 35 manufacture of: 36 (1) cannabis; or 37 (2) paraphernalia used in connection with cannabis; 38 is lawful if the use or possession complies with this article. 39 However, this article does not authorize a person to operate a 40 motor vehicle, a motorboat, or any other device or equipment 41 while under the influence of cannabis. 42 Sec. 2. The use of medical cannabis is subject to the following: 2024 IN 99—LS 6236/DI 106 9 1 (1) Cannabis may be sold only to: 2 (A) a patient who receives a certification from a physician 3 and is in possession of a valid patient or caregiver 4 identification card issued by the ICC that authorizes sale 5 of cannabis to the patient; 6 (B) a caregiver who possesses a valid patient or caregiver 7 identification card issued by the ICC; or 8 (C) a research facility authorized by the ICC, under terms 9 and conditions established by the ICC. 10 (2) If a physician has ordered that cannabis be sold in a 11 specific form, cannabis may be sold only in that form. 12 (3) An individual may not act as a caregiver for more than ten 13 (10) patients. 14 (4) A patient may designate up to two (2) caregivers at any 15 one (1) time. 16 (5) Cannabis that has not been used by the patient shall be 17 kept in the original package in which it was sold. 18 (6) A patient or caregiver shall possess a patient or caregiver 19 identification card whenever the patient or caregiver is in 20 possession of cannabis. 21 Sec. 3. The use of adult use cannabis is subject to the following: 22 (1) Adult use cannabis may be sold only to an adult cannabis 23 user. 24 (2) In any thirty (30) day period, an adult cannabis user may 25 possess not more than one (1) ounce of cannabis. 26 (3) If cannabis is transported in a motor vehicle, it must be 27 kept in a secured and sealed container. 28 (4) An adult cannabis user may not cultivate cannabis. 29 (5) To purchase adult use cannabis, the purchaser must 30 present a valid, government issued photo identification card 31 displaying the person's date of birth. 32 Sec. 4. A product packaged by a cannabis organization may be 33 identified only by: 34 (1) the name of the grower or processor; 35 (2) the name of the qualified retailer; 36 (3) the form and species of cannabis; 37 (4) the percentage of tetrahydrocannabinol and cannabinol 38 contained in the product; 39 (5) the harvest or manufacture date, as applicable; and 40 (6) any other labeling required by the ICC. 41 Sec. 5. (a) Except as expressly otherwise provided in this article, 42 the possession or use of cannabis is unlawful. 2024 IN 99—LS 6236/DI 106 10 1 (b) In addition to any other penalty provided by law, the 2 unlawful possession or use of cannabis may be a crime under 3 IC 35-48-4. 4 Sec. 6. The following acts are unlawful: 5 (1) To grow cannabis unless the person: 6 (A) is a grower that has received a permit from the ICC; 7 (B) is a patient with a valid patient or caregiver 8 identification card who is authorized to cultivate cannabis 9 for personal use under this article; or 10 (C) is a research facility authorized by the ICC. 11 (2) To sell cannabis unless the qualified retailer has received 12 a permit from the ICC. 13 Chapter 4. Physicians 14 Sec. 1. (a) A physician who issues a certification to a patient 15 under this article may not have an ownership interest in a cannabis 16 organization. 17 (b) A physician may issue a certification to a patient only if the 18 physician: 19 (1) establishes and intends to maintain a bona fide 20 physician-patient relationship with the patient for the 21 provision of medical services that is established by an 22 in-person visit and for which there is an expectation that the 23 physician will provide care to the patient on an ongoing basis; 24 or 25 (2) establishes coordination with the patient's existing 26 primary care physician for treatment of the patient's serious 27 medical condition. 28 (c) A physician who violates this section may be subject to 29 professional discipline. 30 Sec. 2. A physician may issue a certification to use cannabis to 31 a patient if the following requirements are met: 32 (1) The physician has determined that the patient has a 33 serious medical condition and has included the serious 34 medical condition in the patient's health care record. 35 (2) The patient is under the physician's continuing care for the 36 serious medical condition, except as provided in section 37 1(b)(2) of this chapter. 38 (3) The physician has determined the patient is likely to 39 receive therapeutic or palliative benefit from the use of 40 cannabis. 41 Sec. 3. A physician issuing a certification under section 1(b)(2) 42 of this chapter may not issue a certification unless the physician 2024 IN 99—LS 6236/DI 106 11 1 has contacted the patient's existing primary care physician to 2 discuss the patient's serious medical condition and which form of 3 cannabis the patient is likely to benefit from. 4 Sec. 4. A certification must include the following information: 5 (1) The patient's name, date of birth, and address. 6 (2) The specific serious medical condition of the patient. 7 (3) A statement by the physician that the patient has a serious 8 medical condition and the patient is under continuing care for 9 the serious medical condition that is provided by: 10 (A) the physician; or 11 (B) the patient's existing primary care physician (as 12 described under section 1(b)(2) of this chapter). 13 (4) The date of issuance. 14 (5) The name, address, telephone number, and signature of 15 the physician. 16 (6) Any requirement or limitation concerning the appropriate 17 form of cannabis, the maximum quantity of cannabis that the 18 patient may use, and any limitation on the duration of use, if 19 applicable. 20 Sec. 5. A physician shall do the following: 21 (1) Provide the certification to the patient. 22 (2) Provide a copy of the certification to the ICC, which shall 23 place the information in the patient directory within the ICC's 24 electronic data base. The certification may be transmitted to 25 the ICC electronically. 26 (3) File a copy of the certification in the patient's health care 27 record. 28 Sec. 6. A physician may not issue a certification for the 29 physician's own use or for the use of a family or household member 30 of the physician. 31 Chapter 5. Certification Form 32 Sec. 1. The ICC shall develop a standard certification form, 33 which the ICC shall provide to a physician upon request. The form 34 must be available electronically. The form must include a 35 statement that a false statement made by a physician is punishable 36 under the penalties of perjury. 37 Chapter 6. Patients 38 Sec. 1. The ICC shall issue a patient or caregiver identification 39 card to a patient who has a valid certification and who otherwise 40 meets the requirements of this article. 41 Sec. 2. The ICC shall issue a patient or caregiver identification 42 card to a caregiver designated by the patient in accordance with 2024 IN 99—LS 6236/DI 106 12 1 this article. 2 Sec. 3. Except as provided in section 4 of this chapter, a patient 3 or caregiver identification card issued to a patient authorizes the 4 patient to obtain and use cannabis as authorized by this article. 5 Except as provided in section 4 of this chapter, a patient or 6 caregiver identification card issued to a caregiver authorizes the 7 caregiver to obtain cannabis on behalf of the patient. 8 Sec. 4. (a) A patient holding a valid patient or caregiver 9 identification card may cultivate cannabis for the patient's own use 10 if the patient complies with the following requirements: 11 (1) The patient notifies the ICC on or before the date that the 12 patient begins cultivation and informs the ICC of the number 13 of plants the patient intends to cultivate and the location of 14 cultivation. 15 (2) The patient cultivates not more than six (6) plants. 16 (3) Not more than three (3) of the plants may be mature at 17 any one (1) time. 18 (4) Cannabis from the plant is used only for the patient's 19 personal use. 20 (5) Not later than thirty (30) days before the expected date 21 that the plants become mature, the patient notifies the ICC of 22 the anticipated maturity date. 23 (b) If the mature plants of a patient cultivating cannabis for the 24 patient's own use die, become damaged, or are otherwise unable to 25 produce cannabis for medical use, the patient shall notify the ICC, 26 which shall reinstate the patient's authorization to obtain cannabis 27 from a qualified retailer not later than fifteen (15) days after 28 receipt of the notice. 29 Chapter 7. Patient or Caregiver Identification Cards 30 Sec. 1. The ICC shall do the following: 31 (1) Review applications for patient or caregiver identification 32 cards. 33 (2) Review certifications submitted by physicians. 34 (3) Issue patient or caregiver identification cards to patients 35 and caregivers. 36 (4) Note in the electronic data base if a patient or caregiver 37 identification card may not be used to obtain cannabis from 38 a qualified retailer because the patient is cultivating the 39 patient's own cannabis. 40 Sec. 2. A patient or caregiver may apply, in a form and manner 41 prescribed by the ICC, for issuance or renewal of a patient or 42 caregiver identification card. A caregiver must submit a separate 2024 IN 99—LS 6236/DI 106 13 1 application for issuance or renewal. Each application must include: 2 (1) the name, address, and date of birth of the patient; 3 (2) the name, address, and date of birth of a caregiver, if 4 applicable; 5 (3) a copy of the certification issued by the physician; 6 (4) the name, address, and telephone number of the physician; 7 (5) the signature of the applicant and the date signed; and 8 (6) any other information required by the ICC. 9 Sec. 3. The fee to apply for or to renew a patient or caregiver 10 identification card is fifty dollars ($50). The ICC may waive or 11 reduce the fee if the applicant demonstrates financial hardship. 12 Sec. 4. The ICC shall make application and renewal forms 13 available on the ICC's website. 14 Sec. 5. (a) The patient or caregiver identification card of a 15 patient or caregiver expires one (1) year after the date of issuance, 16 unless a physician has specified that a patient should use cannabis 17 for less than one (1) year. 18 (b) If a physician has specified that a patient's use of cannabis 19 should be limited to certain forms of cannabis, the forms of 20 cannabis must be listed on the patient or caregiver identification 21 card. 22 Sec. 6. (a) The ICC shall issue separate patient or caregiver 23 identification cards for a patient and a caregiver as soon as 24 reasonably practicable after receiving a properly completed 25 application. 26 (b) If the ICC determines that an application is incomplete or 27 factually inaccurate, the ICC shall promptly notify the applicant. 28 (c) If a patient application designates an individual as a 29 caregiver who is not authorized to be a caregiver, the ICC shall 30 deny that portion of the application, but may approve the balance 31 of the application. 32 Sec. 7. (a) A patient or caregiver who has been issued a patient 33 or caregiver identification card shall notify the ICC not later than 34 ten (10) days after any change of name or address. 35 (b) A patient shall notify the ICC within ten (10) days if a 36 physician has determined the patient no longer has the serious 37 medical condition noted on the certification. 38 Sec. 8. (a) If the patient or caregiver identification card of a 39 patient or caregiver is lost, stolen, destroyed, or made illegible, the 40 patient or caregiver shall apply to the ICC for a replacement card 41 not later than ten (10) days after discovery of the loss or 42 defacement. The application for a replacement card shall be on a 2024 IN 99—LS 6236/DI 106 14 1 form furnished by the ICC and accompanied by a twenty-five 2 dollar ($25) fee. The ICC may establish higher fees for issuance of 3 second and subsequent replacement patient or caregiver 4 identification cards. 5 (b) The ICC may waive or reduce the fee in cases of 6 demonstrated financial hardship. 7 (c) The ICC shall issue a replacement patient or caregiver 8 identification card as soon as practicable. 9 (d) A patient or caregiver may not obtain cannabis from a 10 qualified retailer until the ICC issues the replacement card. 11 Sec. 9. The patient or caregiver identification card must contain 12 the following information: 13 (1) The name of the patient or caregiver, as applicable. The 14 patient or caregiver identification card must also state 15 whether the individual is designated as a patient or as a 16 caregiver. 17 (2) The date of issuance and expiration date. 18 (3) A unique identification number for the patient or 19 caregiver, as applicable. 20 (4) A photograph of the individual to whom the patient or 21 caregiver identification card is issued. 22 (5) Any requirement or limitation set by the physician as to 23 the form of cannabis. 24 (6) Any other requirements as determined by the ICC. 25 However, the ICC may not require that a patient or caregiver 26 identification card disclose the patient's serious medical 27 condition. 28 The ICC shall establish guidelines specifying an acceptable 29 photograph under subdivision (4) and shall provide a reasonable 30 accommodation for a patient who is confined to the patient's home 31 or is in inpatient care. 32 Sec. 10. The ICC shall monthly transmit fees received under this 33 chapter to the state comptroller for deposit in the state general 34 fund. 35 Chapter 8. Caregivers 36 Sec. 1. (a) A caregiver must be at least eighteen (18) years of 37 age. 38 (b) A caregiver may be less than twenty-one (21) years of age 39 only if the ICC determines that it is in the best interests of the 40 patient that a specific person less than twenty-one (21) years of age 41 serves as a caregiver. 42 Sec. 2. (a) A patient may terminate a person's designation as 2024 IN 99—LS 6236/DI 106 15 1 caregiver at any time. 2 (b) The patient shall notify the ICC that the patient has 3 terminated the person's caregiver designation as soon as 4 reasonably practicable after the termination. 5 (c) Upon learning that a patient has terminated a person's 6 caregiver designation, the ICC shall cancel the caregiver's patient 7 or caregiver identification card and notify the caregiver to return 8 the physical copy of the card. 9 Sec. 3. If a patient designates a caregiver, the caregiver may 10 submit an application for a patient or caregiver identification card 11 as a caregiver. The caregiver application must include: 12 (1) the name, address, and date of birth of the caregiver; 13 (2) if the caregiver has a patient or caregiver identification 14 card for the caregiver (as a patient) or another patient (as a 15 caregiver), the expiration date of each patient or caregiver 16 identification card; and 17 (3) any other information required by the ICC. 18 The application must be signed and dated by the caregiver 19 applicant and verified under penalties of perjury. 20 Sec. 4. (a) Except as provided in subsection (c), before the 21 caregiver application is approved, the caregiver must authorize the 22 ICC to perform a national criminal history background check of 23 the caregiver. 24 (b) The caregiver is responsible for the fee for the national 25 criminal history background check. 26 (c) The ICC may conduct only one (1) national criminal history 27 background check of the caregiver per year. 28 Sec. 5. The caregiver shall pay an application fee of fifty dollars 29 ($50). The ICC may waive or reduce the fee in cases of 30 demonstrated financial hardship. 31 Sec. 6. After receiving the caregiver application, the fee, and the 32 results of the national criminal history background check, the ICC 33 shall: 34 (1) verify the information contained in the application; and 35 (2) review INSPECT with respect to the applicant. 36 Sec. 7. The ICC shall monthly transmit fees received under this 37 chapter to the state comptroller for deposit in the state general 38 fund. 39 Chapter 9. Minor Patients 40 Sec. 1. If a patient is less than eighteen (18) years of age, the 41 following apply: 42 (1) The patient must have a caregiver. 2024 IN 99—LS 6236/DI 106 16 1 (2) The caregiver must be: 2 (A) the patient's parent or legal guardian; 3 (B) an individual designated by a parent or legal guardian; 4 or 5 (C) an appropriate individual approved by the ICC on a 6 sufficient showing that no parent or legal guardian is 7 appropriate or available. 8 Chapter 10. Suspension 9 Sec. 1. If a patient or caregiver knowingly, intentionally, or 10 recklessly: 11 (1) violates any provision of this article; or 12 (2) transfers or sells cannabis to a person not qualified as a 13 patient under this article; 14 the ICC may suspend or revoke the patient's or caregiver's patient 15 or caregiver identification card. The suspension or revocation is in 16 addition to any criminal or other penalty. 17 Chapter 11. General Prohibitions 18 Sec. 1. A person may not operate a motor vehicle, including a 19 motorboat, while under the influence of cannabis. 20 Sec. 2. A person may not perform any employment duties in 21 exposed high places or in confined spaces while under the influence 22 of cannabis. 23 Sec. 3. A person's employer may prohibit an employee from 24 performing any task while under the influence of cannabis. The 25 prohibition is not an adverse employment decision or unlawful 26 discrimination even if the prohibition results in financial harm for 27 the employee. 28 Chapter 12. Cannabis Organizations 29 Sec. 1. The following entities may receive a permit to operate as 30 a cannabis organization to grow, process, or sell cannabis: 31 (1) A grower. 32 (2) A processor. 33 (3) A qualified retailer. 34 Sec. 2. (a) The ICC shall develop an application for a: 35 (1) grower permit allowing the grower to grow cannabis; 36 (2) qualified retailer permit allowing a qualified retailer to sell 37 cannabis; 38 (3) processor permit allowing a processor to process cannabis; 39 and 40 (4) testing laboratory permit allowing a testing laboratory to 41 test cannabis. 42 (b) The following information must be included in the permit 2024 IN 99—LS 6236/DI 106 17 1 application: 2 (1) The name, address, telephone number, and other contact 3 information for every person having an ownership interest in 4 the cannabis organization. 5 (2) Information relating to a similar permit, license, or other 6 authorization granted in another jurisdiction, including any 7 suspensions, revocations, or discipline in that jurisdiction. 8 (3) A release authorizing the ICC to conduct a background 9 check of the persons having an ownership interest in the 10 cannabis organization. 11 (4) A statement as to whether the applicant intends to operate 12 as a grower, a processor, or a qualified retailer, and a concise 13 description of the business activities in which the cannabis 14 organization intends to engage. 15 (5) The address or other location where the cannabis 16 organization intends to operate. 17 (6) A statement that no person having an ownership interest 18 in the cannabis organization has a felony conviction related to 19 the production, possession, or sale of marijuana that has not 20 been expunged and that was entered within the three (3) years 21 prior to submission of the permit application. 22 (7) Any other information required by the ICC. 23 (c) A permit application described in this section shall be 24 verified and completed subject to the penalties of perjury. 25 (d) An applicant shall submit the appropriate application and 26 permit fees at the time the applicant submits the application. 27 Chapter 13. Cannabis Organization Permits 28 Sec. 1. Subject to the limits and conditions described in section 29 10 of this chapter, the ICC may grant a cannabis organization a 30 permit if the ICC makes the following findings: 31 (1) The applicant will maintain effective control of cannabis 32 in the custody of the applicant. 33 (2) The applicant will comply with all state statutes, all rules 34 adopted by the ICC, and any ordinances adopted by a 35 governmental unit. 36 (3) The applicant has the ability to properly carry out the 37 activity for which the permit is sought. 38 (4) The applicant has sufficient financial means to acquire all 39 property, equipment, and permits required to properly grow, 40 process, or sell cannabis. 41 (5) The applicant is able to implement and maintain 42 appropriate security, tracking, record keeping, and 2024 IN 99—LS 6236/DI 106 18 1 surveillance systems relating to the acquisition, possession, 2 growth, manufacture, delivery, transportation, distribution, 3 or sale of cannabis. 4 (6) The applicant satisfies any other conditions required 5 under rules adopted by the ICC. 6 (7) Granting a permit to the applicant serves the public 7 interest. 8 Sec. 2. If the ICC finds that information included in the 9 application is insufficient for the ICC to grant a permit to the 10 cannabis organization, the ICC may request that the applicant 11 submit additional documentation relating to one (1) or more items 12 listed in section 1 of this chapter. 13 Sec. 3. (a) Except as provided under subsection (b), a permit 14 granted under this chapter is nontransferable. 15 (b) A permit holder may transfer a permit to a person 16 authorized to hold a permit in accordance with rules adopted by 17 the ICC if: 18 (1) the permit holder has held the permit for at least 19 twenty-four (24) months; or 20 (2) the transfer is necessary due to the death or disability of 21 the permit holder or a similar severe hardship. For purposes 22 of this subdivision, financial hardship is not a severe hardship. 23 Sec. 4. A permit granted under this chapter is valid for one (1) 24 year after the date of issuance. 25 Sec. 5. (a) A permit may be renewed for one (1) or more 26 additional one (1) year periods. 27 (b) The ICC shall establish deadlines for filing a renewal 28 application that provide the ICC with sufficient time to review the 29 application without causing an interruption in the cannabis 30 organization's activities. 31 (c) The same standards that apply for granting an initial 32 application apply to an application for renewal. In determining 33 whether the renewal of a permit serves the public interest, the ICC 34 shall consider the manner in which the renewal applicant has 35 operated the cannabis organization and complied with all relevant 36 laws. 37 Sec. 6. A permit issued by the ICC to a cannabis organization 38 must include the following information: 39 (1) The name and address of the cannabis organization. 40 (2) The type of permit. 41 (3) The activities that are permitted under the permit. 42 (4) A description of the property and facilities authorized to 2024 IN 99—LS 6236/DI 106 19 1 be used by the cannabis organization. 2 (5) Any other information required by the ICC. 3 Sec. 7. The ICC may suspend or revoke all or part of a permit 4 granted under this chapter if, following a hearing, the ICC finds 5 any of the following: 6 (1) That one (1) or more of the determinations made under 7 section 1 of this chapter are no longer valid. 8 (2) That the cannabis organization knowingly or intentionally 9 sold or distributed cannabis to a person not permitted to 10 receive cannabis under this article. 11 (3) That the cannabis organization has failed to maintain 12 effective control against diversion of cannabis. 13 (4) That the cannabis organization has violated a provision of 14 this article or a rule adopted by the ICC. 15 (5) That the cannabis organization has failed to comply with 16 another law regulating controlled substances. 17 Sec. 8. (a) An applicant for a cannabis organization permit has 18 a continuing duty to notify the ICC of any material change in facts 19 or circumstances relating to the applicant's application, including 20 a change in ownership. 21 (b) An applicant's duty to notify the ICC begins on the date the 22 applicant submits the application and continues for as long as the 23 applicant holds a permit. 24 Sec. 9. The ICC may, upon request of a permit holder, amend an 25 existing permit to authorize a permit holder to: 26 (1) move the permit holder's operations from one (1) location 27 to another; or 28 (2) perform additional activities, or cease the performance of 29 certain activities now performed, at the permit holder's 30 facility; 31 if the ICC finds that the amendment is reasonable under the 32 circumstances. 33 Sec. 10. (a) The ICC shall initially issue: 34 (1) ten (10) processor permits; and 35 (2) one hundred (100) grower permits. 36 (b) The ICC shall ensure that, to the extent practicable: 37 (1) at least one (1) processor permit is issued for a facility 38 located in each geographical region described in 39 IC 10-11-2-5(d); 40 (2) at least three (3) grower permits are issued for cultivation 41 in each geographical region described in IC 10-11-2-5(d); and 42 (3) the persons receiving a permit reflect the diversity and 2024 IN 99—LS 6236/DI 106 20 1 makeup of Indiana. 2 (c) The ICC may issue additional permits in order to meet the 3 demand for cannabis in Indiana and to ensure a competitive 4 market. The ICC shall annually complete a market analysis to 5 determine whether additional permits are needed to continue the 6 capture of market share from illicit sources. The ICC shall hold 7 public hearings as part of the market analysis to hear from 8 consumers, market stakeholders, and potential new applicants. 9 Chapter 14. General Duties of a Permit Holder 10 Sec. 1. The holder of a cannabis organization permit must do the 11 following: 12 (1) Report the loss, theft, or unexplained disappearance of 13 cannabis to a law enforcement agency not later than 14 twenty-four (24) hours after the loss, theft, or disappearance 15 is discovered. 16 (2) Permit announced or unannounced inspections by the ICC 17 of all cannabis organization facilities and records. 18 Chapter 15. Application and Permit Fees 19 Sec. 1. The following fees apply to a grower: 20 (1) A nonrefundable grower permit application fee of five 21 hundred dollars ($500). 22 (2) A refundable grower permit fee of two thousand five 23 hundred dollars ($2,500). 24 (3) A refundable grower permit renewal fee of one thousand 25 dollars ($1,000). 26 (4) A nonrefundable permit amendment fee of two hundred 27 fifty dollars ($250). 28 Sec. 2. The following fees apply to a processor: 29 (1) A nonrefundable processor permit application fee of two 30 thousand five hundred dollars ($2,500). 31 (2) A refundable processor permit fee of ten thousand dollars 32 ($10,000). 33 (3) A refundable processor permit renewal fee of five 34 thousand dollars ($5,000). 35 (4) A nonrefundable permit amendment fee of two hundred 36 fifty dollars ($250). 37 Sec. 3. The following fees apply to a qualified retailer: 38 (1) A nonrefundable qualified retailer permit application fee 39 of two hundred dollars ($200). 40 (2) A refundable qualified retailer permit fee of one thousand 41 dollars ($1,000) for each qualified retailer location. 42 (3) A refundable qualified retailer permit renewal fee of seven 2024 IN 99—LS 6236/DI 106 21 1 hundred fifty dollars ($750) for each qualified retailer 2 location. 3 (4) A nonrefundable permit amendment fee of two hundred 4 fifty dollars ($250). 5 Sec. 4. The following fees apply to a testing laboratory: 6 (1) A nonrefundable testing laboratory permit application fee 7 of one thousand dollars ($1,000). 8 (2) A refundable testing laboratory permit fee of two 9 thousand five hundred dollars ($2,500) for each testing 10 laboratory location. 11 (3) A refundable testing laboratory permit renewal fee of two 12 thousand dollars ($2,000) for each testing laboratory location. 13 (4) A nonrefundable permit amendment fee of two hundred 14 fifty dollars ($250). 15 Sec. 5. An applicant must submit the application fee and permit 16 fee at the time the applicant submits the application. 17 Sec. 6. (a) The ICC shall retain the application fee even if the 18 application is not approved. 19 (b) The ICC shall refund the permit fee and renewal fee if the 20 permit or renewal is not approved. However, the permit fee and 21 renewal fee are not refundable if the permit is initially granted but 22 later suspended or revoked. 23 (c) The ICC shall retain the amendment fee even if the 24 application for amendment is not approved. 25 Sec. 7. The ICC shall transfer all fees to the state comptroller 26 for deposit in the state general fund. 27 Chapter 16. Tracking and Record Keeping 28 Sec. 1. (a) A cannabis organization must implement an 29 electronic inventory tracking system, which must be directly 30 accessible to the ICC through an electronic data base that is 31 updated at least one (1) time each day. 32 (b) The electronic inventory tracking system must include the 33 following: 34 (1) For a grower, a seed to sale tracking system that tracks the 35 cannabis from seed to plant until the cannabis is sold or 36 transferred to its final destination. 37 (2) For a processor, a system that tracks cannabis from its 38 purchase from a grower to its transfer to a qualified retailer, 39 testing laboratory, or research facility as authorized by this 40 article. 41 (3) For a qualified retailer, a system that tracks cannabis from 42 its purchase from a grower or processor to its sale to an adult 2024 IN 99—LS 6236/DI 106 22 1 cannabis user, patient, or caregiver, or its transfer to a testing 2 laboratory, research facility, grower, or processor as 3 authorized by this article. 4 (4) For a qualified retailer, a system to verify that a patient or 5 caregiver identification card presented by a patient or 6 caregiver purchasing cannabis: 7 (A) is valid; and 8 (B) authorizes the patient or caregiver to receive cannabis 9 from a qualified retailer. 10 (5) For a qualified retailer, a system to record and transmit 11 the identification of an adult cannabis user and the quantity 12 and type of cannabis purchased to ensure that the adult 13 cannabis user complies with possession limits. 14 (6) For a cannabis organization, a: 15 (A) daily log of each day's beginning inventory, 16 acquisitions, amounts purchased and sold, disbursements, 17 disposals, and ending inventory, including prices paid and 18 amounts collected from adult cannabis users, patients, and 19 caregivers; 20 (B) system to recall defective cannabis; and 21 (C) system to track the waste resulting from the growth of 22 cannabis, including the name and address of a disposal 23 service. 24 Sec. 2. A cannabis organization must implement a plan for: 25 (1) security and surveillance; and 26 (2) record keeping and record retention. 27 Sec. 3. The ICC: 28 (1) shall require a cannabis organization to make an annual 29 report to the ICC; and 30 (2) may require a cannabis organization to make a quarterly 31 report to the ICC. 32 The ICC shall determine the form and contents of the report and 33 may make all or part of the report available to the public. 34 Chapter 17. Grower Operations 35 Sec. 1. A person holding a grower permit may do all the 36 following in accordance with rules adopted by the ICC: 37 (1) Obtain seed and plant material from another grower. 38 (2) Sell and transport seed and plant material to another 39 grower or processor. 40 (3) Sell and transport cannabis to a processor, qualified 41 retailer, testing laboratory, or research facility authorized by 42 the ICC. 2024 IN 99—LS 6236/DI 106 23 1 The ICC may authorize a person holding a grower permit to sell 2 and transport seed, plant material, and cannabis to a grower, 3 processor, qualified retailer, testing laboratory, or research facility 4 in another state. 5 Sec. 2. The ICC shall determine the manner in which cannabis 6 may be grown, harvested, and stored at the cultivation or 7 harvesting facility. 8 Sec. 3. The ICC shall determine the manner in which 9 transportation of cannabis shall be conducted between or among 10 growers, processors, qualified retailers, testing laboratories, or 11 research facilities. Rules adopted by the ICC must include the 12 following: 13 (1) Requirements relating to shipping containers and 14 packaging. 15 (2) The manner in which trucks, vans, trailers, or other 16 carriers will be secured. 17 (3) Obtaining copies of driver's licenses and registrations and 18 other information related to security and tracking. 19 (4) The use of a GPS tracking system. 20 (5) Record keeping requirements for delivery and receipt of 21 cannabis products. 22 Sec. 4. A grower shall contract with an independent testing 23 laboratory to test the cannabis produced by the grower. The ICC 24 shall approve the testing laboratory and require that the testing 25 laboratory report testing results in the manner determined by the 26 ICC. If a grower learns that the grower's sample has failed 27 required testing, the grower must take steps to remediate the 28 harvest to allowable levels under IC 7.1-8-20-3, or immediately 29 dispose of the harvest. 30 Chapter 18. Processor Operations 31 Sec. 1. A person holding a processor permit may do all the 32 following in accordance with rules adopted by the ICC: 33 (1) Obtain cannabis from a grower. 34 (2) Sell and transport processed cannabis to another grower 35 or processor. 36 (3) Sell and transport cannabis to a processor, qualified 37 retailer, testing laboratory, or research facility authorized by 38 the ICC. 39 The ICC shall authorize a person holding a processor permit to sell 40 and transport processed cannabis to a grower, processor, qualified 41 retailer, testing laboratory, or research facility in another state if 42 the person meets the requirements established by the ICC. 2024 IN 99—LS 6236/DI 106 24 1 Sec. 2. The ICC shall determine the manner in which cannabis 2 may be processed or stored at the processor facility. 3 Sec. 3. The ICC shall determine the manner in which 4 transportation of cannabis shall be conducted between or among 5 cannabis organizations and research facilities. Rules adopted by 6 the ICC must include the following: 7 (1) Requirements relating to shipping containers and 8 packaging. 9 (2) The manner in which trucks, vans, trailers, or other 10 carriers will be secured. 11 (3) Obtaining copies of driver's licenses and registrations and 12 other information related to security and tracking. 13 (4) The use of a GPS tracking system. 14 (5) Record keeping requirements for delivery and receipt of 15 cannabis products. 16 Sec. 4. A processor shall develop a plan to ensure that cannabis 17 products are properly labeled, are not packaged in a manner that 18 is appealing to children, and are placed in child resistant 19 packaging. 20 Sec. 5. A processor shall include on its labeling of cannabis 21 products the following: 22 (1) The number of doses contained within the package, the 23 species, and the percentage of tetrahydrocannabinol and 24 cannabinol. 25 (2) A warning that the cannabis must be kept in the original 26 container in which it was sold. 27 (3) A warning that unauthorized use is unlawful and will 28 subject the person to criminal penalties. 29 (4) A list of ingredients. 30 (5) The manufacture or harvest date. 31 (6) Any other information required by the ICC. 32 Sec. 6. A processor shall contract with an independent testing 33 laboratory to test the cannabis product produced by the processor. 34 The testing laboratory must be approved by the ICC, and the ICC 35 shall require that the testing laboratory report testing results in the 36 manner determined by the ICC. If a processor learns that a sample 37 submitted by the processor has failed required testing, the 38 processor must take steps to remediate the product to allowable 39 levels under IC 7.1-8-20-3, or immediately dispose of the batch. 40 Chapter 19. Qualified Retailer Operations 41 Sec. 1. (a) A qualified retailer holding a valid permit under this 42 article may sell cannabis to a patient or caregiver upon 2024 IN 99—LS 6236/DI 106 25 1 presentation of a valid patient or caregiver identification card for 2 that patient or caregiver and electronic verification that the patient 3 or caregiver identification card is valid and authorizes the patient 4 or caregiver to receive cannabis from a qualified retailer. 5 (b) A qualified retailer holding a valid permit under this article 6 may sell cannabis to an adult cannabis user upon presentation of 7 a valid government issued photo identification card containing the 8 person's date of birth, and electronic verification that: 9 (1) the sale will not permit the adult cannabis user to exceed 10 the limit described in section 3 of this chapter; and 11 (2) the adult cannabis user does not possess a valid, unexpired 12 certification. 13 Sec. 2. The qualified retailer shall provide to the purchaser a 14 receipt including all of the following: 15 (1) The name and address of the qualified retailer. 16 (2) The name and address of the purchaser. 17 (3) The date the cannabis was sold. 18 (4) For medical cannabis, any requirement or limitation by 19 the physician as to the form of cannabis for the patient. 20 (5) The form and the quantity of cannabis sold. 21 Sec. 3. A qualified retailer may not sell to a patient (or a 22 caregiver on behalf of a specific patient): 23 (1) in any thirty (30) day period: 24 (A) more cannabis than the maximum amount authorized 25 by the certification; or 26 (B) ten (10) ounces of cannabis; 27 whichever is less; 28 (2) subject to subdivision (1), more than two and one-half (2.5) 29 ounces of cannabis per day, of which not more than fifteen 30 (15) grams may be cannabis concentrate; 31 (3) a form of cannabis that is not authorized on the 32 certification; or 33 (4) cannabis, if the patient is cultivating mature cannabis 34 plants for the patient's own use. 35 Sec. 4. The cannabis packaging must include the following 36 information: 37 (1) The number of doses contained within the package, the 38 species, and the percentage of tetrahydrocannabinol and 39 cannabinol. 40 (2) A warning that the cannabis must be kept in the original 41 container in which it was sold. 42 (3) A warning that unauthorized use is unlawful and will 2024 IN 99—LS 6236/DI 106 26 1 subject the person to criminal penalties. 2 (4) Any other information required by the ICC. 3 Sec. 5. A qualified retailer: 4 (1) may sell cannabis only in an indoor, enclosed, secure 5 facility located in Indiana; 6 (2) may sell medical devices and instruments that are needed 7 to administer cannabis; and 8 (3) may sell services approved by the ICC related to the use of 9 cannabis. 10 Sec. 6. A qualified retailer shall post a copy of its permit in a 11 location within its facility in a manner that is easily observable by 12 the public. 13 Sec. 7. A qualified retailer shall establish a plan to: 14 (1) prevent diversion of cannabis and cannabis products; and 15 (2) ensure a patient is not sold more cannabis than is 16 permitted under this article. 17 Chapter 20. Testing Laboratory Operations 18 Sec. 1. A testing laboratory may test cannabis from a cannabis 19 organization in accordance with rules adopted by the ICC if: 20 (1) it holds a valid permit issued under this article; or 21 (2) it is already accredited as a testing laboratory to 22 International Organization for Standardization (ISO) 17025 23 by a third party accrediting body such as the American 24 Association for Laboratory Accreditation (A2LA) or Assured 25 Calibration and Laboratory Accreditation Select Services 26 (ACLASS). 27 Sec. 2. A testing laboratory shall maintain policies and 28 procedures for the secure and proper analytical testing of 29 cannabis, which must include: 30 (1) laboratory analysis techniques, including specific 31 instrumentation and protocols necessary to perform the tests 32 required by the ICC; 33 (2) the implementation of standards and methods for 34 conducting analysis of forms of cannabis in accordance with 35 the requirements of ISO/IEC 17025 "General Requirements 36 for the Competence of Testing and Calibration 37 Laboratories"; and 38 (3) methods of testing to detect: 39 (A) potency levels of tetrahydrocannabinol and 40 cannabinol; 41 (B) microbials; 42 (C) mycotoxins; 2024 IN 99—LS 6236/DI 106 27 1 (D) pesticides; 2 (E) residual solvents; and 3 (F) any other matter as required by the ICC. 4 Sec. 3. The ICC shall establish the allowable level of microbials, 5 mycotoxins, pesticides, residual solvents, and other matter 6 determined by the ICC. If a sample received from a grower or 7 processor exceeds allowable levels, the testing laboratory must 8 immediately notify the grower or processor from whom the testing 9 laboratory received the sample. 10 Sec. 4. A person holding an ownership interest in a qualified 11 retailer, a grower, or a processor permit may not have an 12 ownership interest in a testing laboratory permit. 13 Chapter 21. Transportation 14 Sec. 1. A transporter may transport cannabis or paraphernalia 15 from a: 16 (1) grower or processor to a qualified retailer; 17 (2) grower or processor to a testing laboratory or research 18 facility authorized by the ICC; 19 (3) qualified retailer to a grower or processor; 20 (4) qualified retailer to a testing laboratory or research 21 facility authorized by the ICC; 22 (5) cannabis organization to another cannabis organization; 23 or 24 (6) cannabis organization to another person if authorized to 25 do so by the ICC; 26 if the transporter complies with this chapter. 27 Sec. 2. No employee of a transporter under this chapter who is 28 directly involved in the transport of cannabis or paraphernalia 29 may have a felony conviction related to the production, possession, 30 or sale of marijuana that was entered within the previous three (3) 31 years and that has not been expunged. 32 Sec. 3. Cannabis or paraphernalia transported under this 33 chapter must be: 34 (1) packed in a tamper resistant and tamper evident package; 35 (2) clearly marked as to quantity and contents; and 36 (3) securely stored in the vehicle used for transport. 37 Sec. 4. The transporter shall proceed as directly and 38 expeditiously as practicable from the shipping location to the 39 receiving location. 40 Sec. 5. The person who ships the cannabis or paraphernalia 41 shall provide the transporter with a shipping manifest clearly 42 stating the: 2024 IN 99—LS 6236/DI 106 28 1 (1) exact quantity of cannabis or paraphernalia that is being 2 transported; 3 (2) address of the shipping location; 4 (3) address of the receiving location; 5 (4) identification of the person transporting the material; and 6 (5) time the person transporting the material left the shipping 7 location. 8 Sec. 6. The transporter shall keep the shipping manifest in the 9 transporter's possession at all times. 10 Sec. 7. The ICC may adopt rules to regulate the transport of 11 cannabis or paraphernalia. The ICC may authorize a transporter 12 to transport cannabis or paraphernalia out of state. 13 Chapter 22. Reports 14 Sec. 1. The ICC shall, not later than December 31 of each year, 15 submit a report concerning the cannabis program to the legislative 16 council, the governor, and the chief justice of the supreme court. 17 The report to the legislative council must be in an electronic format 18 under IC 5-14-6. 19 Chapter 23. Civil Penalties 20 Sec. 1. The ICC may assess a civil penalty of not more than 21 twenty thousand dollars ($20,000) for each violation of this article 22 or a rule adopted under this article. In addition, the ICC may 23 impose an additional penalty of not more than two thousand five 24 hundred dollars ($2,500) for each day of a continuing violation. 25 Sec. 2. (a) In determining the amount of a civil penalty imposed 26 under this chapter, the ICC shall consider the following: 27 (1) The seriousness of the violation. 28 (2) The potential harm resulting from the violation to adult 29 cannabis users, patients, caregivers, or the general public. 30 (3) The willfulness of the violation. 31 (4) Any previous violations. 32 (5) The economic benefit that accrued to the person who 33 committed the violation. 34 (b) If the ICC finds that the: 35 (1) violation did not threaten the safety or health of an adult 36 cannabis user, a patient, a caregiver, or the general public; 37 and 38 (2) violator took immediate action to remedy the violation 39 upon learning of it; 40 the ICC may issue a written warning instead of assessing a civil 41 penalty. 42 Sec. 3. In addition to the civil penalty described in this chapter 2024 IN 99—LS 6236/DI 106 29 1 and any other penalty authorized by law, the ICC may revoke or 2 suspend a person's permit or patient or caregiver identification 3 card. 4 Chapter 24. Research 5 Sec. 1. (a) The ICC may provide assistance to universities, 6 research facilities, pharmaceutical companies, state agencies, and 7 similar entities that wish to conduct research concerning cannabis. 8 (b) The ICC may conduct research concerning cannabis. 9 Sec. 2. The ICC may authorize persons conducting research on 10 cannabis to obtain, possess, transport, and use cannabis for 11 research purposes, under terms and conditions established by the 12 ICC. The ICC shall issue appropriate documentation to allow 13 persons to obtain cannabis for research purposes. 14 Chapter 25. Employment 15 Sec. 1. The following definitions apply throughout this chapter: 16 (1) "On call" means that an employee is scheduled with at 17 least twenty-four (24) hours notice by the employee's 18 employer to be on standby or otherwise responsible for 19 performing tasks related to the employee's employment either 20 at the employer's premises or other previously designated 21 location by the employee's employer or supervisor to perform 22 a work related task. 23 (2) "Workplace" means the employer's premises, including 24 any building, real property, and parking area under the 25 control of the employer or area used by an employee while in 26 performance of the employee's job duties, and vehicles, 27 whether leased, rented, or owned. The term includes another 28 location as defined by the employer's written employment 29 policy, to the extent that the policy is generally consistent with 30 this subdivision. 31 Sec. 2. This article does not: 32 (1) prohibit an employer from adopting reasonable zero 33 tolerance or drug free workplace policies, or employment 34 policies concerning drug testing, smoking, consumption, 35 storage, or use of cannabis in the workplace or while on call 36 provided that the policy is applied in a nondiscriminatory 37 manner; 38 (2) require an employer to permit an employee to be under 39 the influence of or use cannabis in the employer's workplace 40 or while performing the employee's job duties or while on 41 call; or 42 (3) limit or prevent an employer from disciplining an 2024 IN 99—LS 6236/DI 106 30 1 employee or terminating employment of an employee for 2 violating an employer's employment policies or workplace 3 drug policies. 4 Sec. 3. For purposes of section 2 of this chapter, an employer 5 may consider an employee to be impaired by or under the influence 6 of cannabis if the employer has a good faith belief that an employee 7 manifests specific, articulable symptoms while working that 8 decrease or lessen the employee's performance of the duties or 9 tasks of the employee's job position, including symptoms of the 10 employee's speech, physical dexterity, agility, coordination, 11 demeanor, irrational or unusual behavior, or negligence or 12 carelessness in operating equipment or machinery; disregard for 13 the safety of the employee or others, or involvement in any accident 14 that results in serious damage to equipment or property; 15 disruption of a production or manufacturing process; or 16 carelessness that results in any injury to the employee or others. If 17 an employer elects to discipline an employee on the basis that the 18 employee is under the influence of or impaired by cannabis, the 19 employer must afford the employee a reasonable opportunity to 20 contest the basis of the determination. 21 Sec. 4. This article does not create or imply a cause of action for 22 any person against an employer for: 23 (1) actions, including subjecting an employee or applicant to 24 reasonable drug and alcohol testing under the employer's 25 workplace drug policy, including an employee's refusal to be 26 tested or to cooperate in testing procedures or disciplining or 27 termination of employment, based on the employer's good 28 faith belief that an employee used or possessed cannabis in the 29 employer's workplace or while performing the employee's job 30 duties or while on call in violation of the employer's 31 employment policies; 32 (2) actions, including discipline or termination of employment, 33 based on the employer's good faith belief that an employee 34 was impaired as a result of the use of cannabis, or under the 35 influence of cannabis, while at the employer's workplace or 36 while performing the employee's job duties or while on call in 37 violation of the employer's workplace drug policy; or 38 (3) injury, loss, or liability to a third party if the employer 39 neither knew nor had reason to know that the employee was 40 impaired. 41 Sec. 5. This article does not enhance or diminish protections 42 afforded by any other law. 2024 IN 99—LS 6236/DI 106 31 1 Sec. 6. This article does not interfere with any federal, state, or 2 local restrictions on employment including the United States 3 Department of Transportation regulation 49 CFR 40.151(e) or 4 impact an employer's ability to comply with federal or state law or 5 cause an employer to lose any federal or state contract or funding. 6 SECTION 6. IC 7.1-9 IS ADDED TO THE INDIANA CODE AS A 7 NEW ARTICLE TO READ AS FOLLOWS [EFFECTIVE JULY 1, 8 2024]: 9 ARTICLE 9. INDIANA CANNABIS COMMISSION 10 Chapter 1. Definitions 11 Sec. 1. The definitions in IC 7.1-8-1-1 apply throughout this 12 article. 13 Chapter 2. General Provisions 14 Sec. 1. The Indiana cannabis commission (ICC) is established as 15 an agency of the executive branch of state government for purposes 16 of administering the cannabis program. 17 Sec. 2. (a) The ICC consists of: 18 (1) the ICC board; 19 (2) the executive director; and 20 (3) other employees necessary to carry out the duties of the 21 ICC. 22 (b) The ICC board is established as a continuing board of the 23 executive branch of state government. 24 (c) The ICC board consists of three (3) commissioners, who shall 25 direct and oversee the operation of the ICC. 26 Sec. 3. (a) The commissioners shall be appointed by the 27 governor. 28 (b) A commissioner serves for a term that ends June 30 of the 29 next odd-numbered year after appointment. A commissioner is 30 eligible for reappointment. 31 (c) Not more than two (2) commissioners may belong to the 32 same political party. 33 (d) A commissioner serves the commissioner's term at the 34 pleasure of the governor. 35 Sec. 4. To be eligible for appointment as a commissioner, an 36 individual must have the following qualifications: 37 (1) The individual may not be employed by the state in any 38 other capacity. 39 (2) The individual must have good moral character. 40 (3) The individual must have been a resident of Indiana for at 41 least ten (10) years immediately preceding the appointment. 42 Sec. 5. The governor shall appoint one (1) commissioner to serve 2024 IN 99—LS 6236/DI 106 32 1 as chairperson of the ICC board, and one (1) commissioner to 2 serve as vice chairperson. The vice chairperson shall act as the 3 chairperson if the chairperson is unable to attend a meeting of the 4 ICC board. The chairperson and vice chairperson serve at the 5 pleasure of the governor. 6 Sec. 6. A commissioner appointed to fill a vacancy in the 7 membership of the ICC board shall serve only for the remainder 8 of the unexpired term. In all other respects, an appointment to fill 9 a vacancy shall be made in the same manner that an original 10 appointment is made. 11 Sec. 7. (a) As compensation for services, each commissioner is 12 entitled to the minimum salary per diem provided by 13 IC 4-10-11-2.1(b). A commissioner is also entitled to 14 reimbursement for traveling expenses as provided under 15 IC 4-13-1-4 and other expenses actually incurred in connection 16 with the commissioner's duties as provided in the state policies and 17 procedures established by the Indiana department of 18 administration and approved by the budget agency. 19 (b) The expenses of the ICC board shall be paid from funds 20 appropriated to the regulatory agency. 21 Sec. 8. Each commissioner shall execute: 22 (1) a surety bond in the amount of ten thousand dollars 23 ($10,000), with surety approved by the governor; and 24 (2) an oath of office. 25 The surety bond and the oath of office shall be filed in the office of 26 the secretary of state. 27 Sec. 9. The required surety bond executed and filed on behalf of 28 a commissioner shall be made payable to the state of Indiana and 29 conditioned upon the faithful discharge of the commissioner's 30 duties. 31 Sec. 10. The ICC board shall hold meetings at the call of the 32 chairperson. The ICC board may establish rules governing 33 meetings. 34 Sec. 11. (a) Two (2) ICC commissioners constitute a quorum for 35 the transaction of business. 36 (b) Each commissioner has one (1) vote. 37 (c) Action of the ICC board may be taken only upon the 38 affirmative votes of at least two (2) commissioners. 39 Sec. 12. An ICC commissioner may not solicit or accept a 40 political contribution from a patient, a caregiver, or any individual 41 or entity that has a permit or has applied for a permit issued by the 42 ICC. However, the right of a commissioner to vote as the 2024 IN 99—LS 6236/DI 106 33 1 commissioner chooses and to express the commissioner's opinions 2 on political subjects and candidates may not be impaired. 3 Chapter 3. Employees and Administration 4 Sec. 1. (a) The ICC board shall appoint an executive director to 5 assist the ICC in the efficient administration of its powers and 6 duties. 7 (b) The ICC board shall fix the salary of the executive director, 8 subject to the approval of the budget agency. 9 Sec. 2. The ICC has the power to employ all necessary 10 employees, determine their duties, and, subject to the approval of 11 the ICC board and the budget agency, fix their salaries. 12 Chapter 4. Powers and Duties 13 Sec. 1. The chairperson is the presiding officer at the meetings 14 of the ICC board. The chairperson, together with the executive 15 director, shall prepare, certify, and authenticate all proceedings, 16 minutes, records, rules, and regulations of the ICC board. The 17 chairperson shall also perform all other duties as imposed on the 18 chairperson by this title. 19 Sec. 2. The ICC has the power to organize its work, to enforce 20 and administer this article and IC 7.1-8, and to enforce and 21 administer the rules adopted by the ICC. 22 Sec. 3. The ICC shall adopt rules under IC 4-22-2 to prescribe 23 the forms for all applications, documents, permits, patient or 24 caregiver identification cards, and licenses used in the 25 administration of this article and IC 7.1-8. 26 Sec. 4. The ICC has the following powers: 27 (1) To hold hearings before the ICC or its representative. 28 (2) To take testimony and receive evidence. 29 (3) To conduct inquiries with or without a hearing. 30 (4) To receive reports of investigators or other governmental 31 officers and employees. 32 (5) To administer oaths. 33 (6) To subpoena witnesses and to compel them to appear and 34 testify. 35 (7) To certify copies of records of the ICC or any other 36 document or record on file with the ICC. 37 (8) To fix the form, mode, manner, time, and number of times 38 for the posting or publication of any required notices if not 39 otherwise provided. 40 (9) To adopt rules under IC 4-22-2 to carry out this article 41 and IC 7.1-8. 42 Sec. 5. The ICC has the following duties: 2024 IN 99—LS 6236/DI 106 34 1 (1) To establish the cannabis program described in IC 7.1-8 2 and to adopt all necessary rules to implement the program. 3 (2) To implement protocols for the application and issuance 4 of a patient or caregiver identification card, including 5 protocols to: 6 (A) prevent fraud; 7 (B) ensure the accuracy of information contained in the 8 application; and 9 (C) protect the privacy of an applicant. 10 (3) To advise the general assembly concerning the 11 establishment of a program for the: 12 (A) manufacture; 13 (B) cultivation; 14 (C) advertising; 15 (D) transportation; and 16 (E) sale; 17 of cannabis. 18 (4) To encourage research concerning cannabis. 19 Chapter 5. Research and Development 20 Sec. 1. To permit and encourage research concerning cannabis: 21 (1) an accredited institution of higher education with a 22 physical presence in Indiana; and 23 (2) a pharmaceutical or agricultural business having a 24 research facility in Indiana; 25 may apply to the ICC for a license to conduct research concerning 26 cannabis. 27 Sec. 2. An application under this chapter must include the 28 following: 29 (1) The nature of the research project. 30 (2) The names of the individuals who will conduct the 31 research project. 32 (3) The approximate quantity of cannabis that will be used in 33 the research project. 34 (4) The security protocol to be implemented to ensure that 35 cannabis is not diverted for uses other than the research 36 project. 37 (5) Any other information required by the ICC. 38 Sec. 3. Upon receipt of a completed application, the ICC may 39 issue a research license to the accredited institution of higher 40 education or pharmaceutical or agricultural business. The research 41 license must specifically list the names of each individual 42 participating in the research project who will have custody or 2024 IN 99—LS 6236/DI 106 35 1 control of cannabis for research purposes and the approximate 2 quantity of the cannabis that will be used in the research project. 3 Sec. 4. The ICC may charge a reasonable fee for issuance of a 4 research license. 5 SECTION 7. IC 9-30-5-1, AS AMENDED BY P.L.49-2021, 6 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 7 JULY 1, 2024]: Sec. 1. (a) A person who operates a vehicle with an 8 alcohol concentration equivalent to at least eight-hundredths (0.08) 9 gram of alcohol but less than fifteen-hundredths (0.15) gram of alcohol 10 per: 11 (1) one hundred (100) milliliters of the person's blood; or 12 (2) two hundred ten (210) liters of the person's breath; 13 commits a Class C misdemeanor. 14 (b) A person who operates a vehicle with an alcohol concentration 15 equivalent to at least fifteen-hundredths (0.15) gram of alcohol per: 16 (1) one hundred (100) milliliters of the person's blood; or 17 (2) two hundred ten (210) liters of the person's breath; 18 commits a Class A misdemeanor. 19 (c) A person who operates a vehicle with a controlled substance 20 listed in schedule I or II of IC 35-48-2 or its metabolite, not including 21 THC, in the person's blood commits a Class C misdemeanor. 22 (d) It is a defense to subsection (c) that: 23 (1) the accused person consumed the controlled substance in 24 accordance with a valid prescription or order of a practitioner (as 25 defined in IC 35-48-1) who acted in the course of the 26 practitioner's professional practice; or 27 (2) the: 28 (A) controlled substance is marijuana or a metabolite of 29 marijuana; 30 (B) person was not intoxicated; 31 (C) person did not cause a traffic accident; and 32 (D) substance was identified by means of a chemical test taken 33 pursuant to IC 9-30-7. 34 (e) A person who: 35 (1) operates a vehicle with at least five (5) nanograms per 36 milliliter of THC in the person's whole blood; and 37 (2) is impaired; 38 commits a Class C misdemeanor. 39 SECTION 8. IC 9-30-5-4, AS AMENDED BY P.L.184-2019, 40 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 41 JULY 1, 2024]: Sec. 4. (a) A person who causes serious bodily injury 42 to another person when operating a vehicle: 2024 IN 99—LS 6236/DI 106 36 1 (1) with an alcohol concentration equivalent to at least 2 eight-hundredths (0.08) gram of alcohol per: 3 (A) one hundred (100) milliliters of the person's blood; or 4 (B) two hundred ten (210) liters of the person's breath; 5 (2) with a controlled substance listed in schedule I or II of 6 IC 35-48-2 or its metabolite, not including THC, in the person's 7 blood; 8 (3) with at least five (5) nanograms per milliliter of THC in 9 the person's whole blood; or 10 (3) (4) while intoxicated; 11 commits a Level 5 felony. However, the offense is a Level 4 felony if 12 the person has a previous conviction of operating while intoxicated 13 within the five (5) years preceding the commission of the offense. 14 (b) A person who violates subsection (a) commits a separate offense 15 for each person whose serious bodily injury is caused by the violation 16 of subsection (a). 17 (c) It is a defense under subsection (a)(2) that the accused person 18 consumed the controlled substance in accordance with a valid 19 prescription or order of a practitioner (as defined in IC 35-48-1) who 20 acted in the course of the practitioner's professional practice. 21 SECTION 9. IC 9-30-5-5, AS AMENDED BY P.L.184-2019, 22 SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 23 JULY 1, 2024]: Sec. 5. (a) A person who causes the death or 24 catastrophic injury of another person when operating a vehicle: 25 (1) with an alcohol concentration equivalent to at least 26 eight-hundredths (0.08) gram of alcohol per: 27 (A) one hundred (100) milliliters of the person's blood; or 28 (B) two hundred ten (210) liters of the person's breath; 29 (2) with a controlled substance listed in schedule I or II of 30 IC 35-48-2 or its metabolite, not including THC, in the person's 31 blood; 32 (3) with at least five (5) nanograms per milliliter of THC in 33 the person's whole blood; or 34 (3) (4) while intoxicated; 35 commits a Level 4 felony. 36 (b) A person who causes the death of a law enforcement animal (as 37 defined in IC 35-46-3-4.5) when operating a vehicle: 38 (1) with an alcohol concentration equivalent to at least 39 eight-hundredths (0.08) gram of alcohol per: 40 (A) one hundred (100) milliliters of the person's blood; or 41 (B) two hundred ten (210) liters of the person's breath; or 42 (2) with a controlled substance listed in schedule I or II of 2024 IN 99—LS 6236/DI 106 37 1 IC 35-48-2 or its metabolite, not including THC, in the person's 2 blood; or 3 (3) with at least five (5) nanograms per milliliter of THC in 4 the person's whole blood; 5 commits a Level 6 felony. 6 (c) A person who commits an offense under subsection (a) or (b) 7 commits a separate offense for each person or law enforcement animal 8 whose death (or catastrophic injury, in the case of a person) is caused 9 by the violation of subsection (a) or (b). 10 (d) It is a defense under subsection (a) or (b) that the person accused 11 of causing the death or catastrophic injury of another person or the 12 death of a law enforcement animal when operating a vehicle with a 13 controlled substance listed in schedule I or II of IC 35-48-2 or its 14 metabolite in the person's blood consumed the controlled substance in 15 accordance with a valid prescription or order of a practitioner (as 16 defined in IC 35-48-1) who acted in the course of the practitioner's 17 professional practice. 18 SECTION 10. IC 9-30-6-6, AS AMENDED BY P.L.174-2021, 19 SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 20 JULY 1, 2024]: Sec. 6. (a) A physician, a person trained in retrieving 21 contraband or obtaining bodily substance samples and acting under the 22 direction of or under a protocol prepared by a physician, or a licensed 23 health care professional acting within the professional's scope of 24 practice and under the direction of or under a protocol prepared by a 25 physician, who: 26 (1) obtains a blood, urine, or other bodily substance sample from 27 a person, regardless of whether the sample is taken for diagnostic 28 purposes or at the request of a law enforcement officer under this 29 section; 30 (2) performs a chemical test on blood, urine, or other bodily 31 substance obtained from a person; or 32 (3) searches for or retrieves contraband from the body cavity of an 33 individual; 34 shall deliver the sample or contraband or disclose the results of the test 35 to a law enforcement officer who requests the sample, contraband, or 36 results as a part of a criminal investigation. Samples, contraband, and 37 test results shall be provided to a law enforcement officer even if the 38 person has not consented to or otherwise authorized their release. 39 (b) A physician, a licensed health care professional, a hospital, or an 40 agent of a physician or hospital is not civilly or criminally liable for any 41 of the following: 42 (1) Disclosing test results in accordance with this section. 2024 IN 99—LS 6236/DI 106 38 1 (2) Delivering contraband, or a blood, urine, or other bodily 2 substance sample in accordance with this section. 3 (3) Searching for or retrieving contraband or obtaining a blood, 4 urine, or other bodily substance sample in accordance with this 5 section. 6 (4) Disclosing to the prosecuting attorney or the deputy 7 prosecuting attorney for use at or testifying at the criminal trial of 8 the person as to facts observed or opinions formed. 9 (5) Failing to treat a person from whom contraband is retrieved or 10 a blood, urine, or other bodily substance sample is obtained at the 11 request of a law enforcement officer if the person declines 12 treatment. 13 (6) Injury to a person arising from the performance of duties in 14 good faith under this section. However, immunity does not apply 15 if the physician, licensed health care professional, hospital, or 16 agent of a physician or hospital acts with gross negligence or 17 willful or wanton misconduct. 18 (c) For the purposes of a criminal proceeding: 19 (1) the privileges arising from a patient-physician relationship do 20 not apply to the contraband, samples, test results, or testimony 21 described in this section; and 22 (2) contraband, samples, test results, and testimony may be 23 admitted in a proceeding in accordance with the applicable rules 24 of evidence. 25 (d) The exceptions to the patient-physician relationship specified in 26 subsection (c) do not affect those relationships in a proceeding that is 27 not a criminal proceeding. 28 (e) The contraband, test results, and samples obtained by a law 29 enforcement officer under subsection (a) may be disclosed only to a 30 prosecuting attorney or a deputy prosecuting attorney for use as 31 evidence in a criminal proceeding. 32 (f) This section does not require a physician or a person under the 33 direction of a physician to perform a chemical test or to retrieve 34 contraband. 35 (g) If the person: 36 (1) from whom the contraband is to be retrieved or the bodily 37 substance sample is to be obtained under this section does not 38 consent; and 39 (2) resists the retrieval of the contraband or the taking of a 40 sample; 41 the law enforcement officer may use reasonable force to assist an 42 individual, who must be authorized under this section to retrieve 2024 IN 99—LS 6236/DI 106 39 1 contraband or obtain a sample, in the retrieval of the contraband or the 2 taking of the sample. 3 (h) The person authorized under this section to retrieve contraband 4 or obtain a bodily substance sample shall take the sample or retrieve 5 the contraband in a medically accepted manner. 6 (i) This subsection does not apply to contraband retrieved or a 7 bodily substance sample taken at a licensed hospital (as defined in 8 IC 16-18-2-179(a) and IC 16-18-2-179(b)). A law enforcement officer 9 may transport the person to a place where the contraband may be 10 retrieved or the sample may be obtained by any of the following 11 persons who are trained in retrieving contraband or obtaining bodily 12 substance samples and who have been engaged to retrieve contraband 13 or obtain samples under this section: 14 (1) A physician holding an unlimited license to practice medicine 15 or osteopathy. 16 (2) A registered nurse. 17 (3) A licensed practical nurse. 18 (4) An advanced emergency medical technician (as defined in 19 IC 16-18-2-6.5). 20 (5) A paramedic (as defined in IC 16-18-2-266). 21 (6) Except as provided in subsections (j) through (k), any other 22 person qualified through training, experience, or education to 23 retrieve contraband or obtain a bodily substance sample. 24 (j) A law enforcement officer may not retrieve contraband or obtain 25 a bodily substance sample under this section if the contraband is to be 26 retrieved or the sample is to be obtained from another law enforcement 27 officer as a result of the other law enforcement officer's involvement in 28 an accident or alleged crime. 29 (k) A law enforcement officer who is otherwise qualified to obtain 30 a bodily substance sample under this section may obtain a bodily 31 substance sample from a person involved in an accident or alleged 32 crime who is not a law enforcement officer only if: 33 (1) the officer obtained a bodily substance sample from an 34 individual as part of the officer's official duties as a law 35 enforcement officer; and 36 (2) the: 37 (A) person consents to the officer obtaining a bodily substance 38 sample; or 39 (B) obtaining of the bodily substance sample is authorized by 40 a search warrant. 41 (l) A physician or a person trained in obtaining bodily samples who 42 is acting under the direction of or under a protocol prepared by a 2024 IN 99—LS 6236/DI 106 40 1 physician shall obtain a blood sample if the following conditions are 2 satisfied: 3 (1) A law enforcement officer requests that the sample be 4 obtained. 5 (2) The law enforcement officer has certified in writing the 6 following: 7 (A) That the officer has probable cause to believe the person 8 from whom the sample is to be obtained has violated 9 IC 9-30-5-4, IC 9-30-5-5, IC 35-46-9-6(b)(2), 10 IC 35-46-9-6(c)(2), or IC 35-46-9-6(c). IC 35-46-9-6(d). 11 (B) That the offense resulting in a criminal investigation 12 described in subsection (a) occurred not more than three (3) 13 hours before the time the sample is requested. 14 (C) That exigent circumstances exist that create pressing 15 health, safety, or law enforcement needs that would take 16 priority over a warrant application. 17 (3) Not more than the use of reasonable force is necessary to 18 obtain the sample. 19 SECTION 11. IC 35-38-9-1.5 IS ADDED TO THE INDIANA 20 CODE AS A NEW SECTION TO READ AS FOLLOWS 21 [EFFECTIVE JULY 1, 2024]: Sec. 1.5. (a) This section applies only 22 to a person convicted of one (1) or more of the following offenses 23 if the act constituting the offense is now permitted under 24 IC 7.1-8-3: 25 (1) IC 35-48-4-8.3 (possession of paraphernalia). 26 (2) IC 35-48-4-8.5 (dealing in paraphernalia). 27 (3) IC 35-48-4-10 (dealing in marijuana). 28 (4) IC 35-48-4-11 (possession of marijuana). 29 (b) A person to whom this section applies may petition a court 30 to expunge all conviction records, including records contained in: 31 (1) a court's files; 32 (2) the files of the department of correction; 33 (3) the files of the bureau of motor vehicles; and 34 (4) the files of any other person who provided treatment or 35 services to the petitioning person under a court order; 36 that relate to the person's conviction, including records of a 37 collateral action. 38 (c) A petition for expungement of records must be verified and 39 filed in a circuit or superior court in the county of conviction. The 40 petition must set forth: 41 (1) the date of the conviction; 42 (2) the county of conviction; 2024 IN 99—LS 6236/DI 106 41 1 (3) the court that entered the conviction; 2 (4) any other known identifying information, such as: 3 (A) the name of the arresting officer; 4 (B) the case number or court cause number; 5 (C) any aliases or other names used by the petitioner; 6 (D) the petitioner's driver's license number; and 7 (E) a list of each criminal charge and its disposition, if 8 applicable; 9 (5) the date of the petitioner's birth; and 10 (6) the petitioner's Social Security number. 11 A person who files a petition under this section is not required to 12 pay a filing fee. 13 (d) The court shall serve a copy of the petition on the 14 prosecuting attorney. 15 (e) Upon receipt of a petition for expungement, the court: 16 (1) may summarily deny the petition if the petition does not 17 meet the requirements of this section, or if the statements 18 contained in the petition indicate that the petitioner is not 19 entitled to relief; and 20 (2) shall grant the petition unless the conditions described in 21 subsection (a) have not been met. 22 (f) Whenever the petition of a person under this section is 23 granted: 24 (1) no information concerning the conviction (including 25 information from a collateral action that identifies the 26 petitioner) may be placed or retained in any state central 27 repository for criminal history information or in any other 28 alphabetically arranged criminal history information system 29 maintained by a local, regional, or statewide law enforcement 30 agency; 31 (2) the clerk of the supreme court shall seal or redact any 32 records in the clerk's possession that relate to the vacated 33 conviction; 34 (3) the records of: 35 (A) the sentencing court; 36 (B) a court that conducted a collateral action; 37 (C) a court of appeals; and 38 (D) the supreme court; 39 concerning the person shall be redacted or permanently 40 sealed; and 41 (4) with respect to the records of a person who is named as an 42 appellant or an appellee in an opinion or memorandum 2024 IN 99—LS 6236/DI 106 42 1 decision by the supreme court or the court of appeals, or who 2 is identified in a collateral action, the court shall: 3 (A) redact the opinion or memorandum decision as it 4 appears on the computer gateway administered by the 5 office of technology so that it does not include the 6 petitioner's name (in the same manner that opinions 7 involving juveniles are redacted); and 8 (B) provide a redacted copy of the opinion to any publisher 9 or organization to whom the opinion or memorandum 10 decision is provided after the date of the order of 11 expungement. 12 The supreme court and the court of appeals are not required to 13 redact, destroy, or otherwise dispose of any existing copy of an 14 opinion or memorandum decision that includes the petitioner's 15 name. 16 (g) If the court issues an order granting a petition for 17 expungement under this section, the order must include the 18 information described in subsection (f). 19 (h) If a person whose records are expunged brings an action that 20 might be defended with the contents of the expunged records, the 21 defendant is presumed to have a complete defense to the action. In 22 order for the plaintiff to recover, the plaintiff must show that the 23 contents of the expunged records would not exonerate the 24 defendant. The plaintiff may be required to state under oath 25 whether the plaintiff had records in the criminal or juvenile justice 26 system and whether those records were expunged. If the plaintiff 27 denies the existence of the records, the defendant may prove their 28 existence in any manner compatible with the law of evidence. 29 SECTION 12. IC 35-46-9-6, AS AMENDED BY P.L.184-2019, 30 SECTION 14, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 31 JULY 1, 2024]: Sec. 6. (a) Except as provided in subsections (b) and 32 (c) and (d), a person who operates a motorboat while: 33 (1) having an alcohol concentration equivalent (as defined in 34 IC 9-13-2-2.4) to at least eight-hundredths (0.08) gram of alcohol 35 per: 36 (A) one hundred (100) milliliters of the person's blood; or 37 (B) two hundred ten (210) liters of the person's breath; 38 (2) having a controlled substance listed in schedule I or II of 39 IC 35-48-2 or its metabolite, not including THC, in the person's 40 body; or 41 (3) intoxicated; 42 commits a Class C misdemeanor. 2024 IN 99—LS 6236/DI 106 43 1 (b) A person who: 2 (1) operates a vehicle with at least five (5) nanograms per 3 milliliter of THC in the person's whole blood; and 4 (2) is impaired; 5 commits a Class C misdemeanor. 6 (b) (c) The offense under subsection (a) or (b) is a Level 6 felony 7 if: 8 (1) the person has a previous conviction under: 9 (A) IC 14-1-5 (repealed); 10 (B) IC 14-15-8-8 (repealed); or 11 (C) this chapter; or 12 (2) the offense results in serious bodily injury to another person. 13 (c) (d) The offense under subsection (a) or (b) is a Level 5 felony 14 if the offense results in the death or catastrophic injury of another 15 person. 16 (d) (e) It is a defense to a prosecution under subsection (a)(2) that 17 the accused person consumed the controlled substance in accordance 18 with a valid prescription or order of a practitioner (as defined in 19 IC 35-48-1-24) who acted in the course of the practitioner's 20 professional practice. 21 SECTION 13. IC 35-48-4-8.3, AS AMENDED BY P.L.187-2015, 22 SECTION 49, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 23 JULY 1, 2024]: Sec. 8.3. (a) This section does not apply to: 24 (1) a rolling paper; or 25 (2) a person, including an adult cannabis user, patient, 26 caregiver, cannabis organization, research facility, or 27 transporter described in IC 7.1-8, if the person is in 28 substantial compliance with the requirements of IC 7.1-8. 29 (b) A person who knowingly or intentionally possesses an 30 instrument, a device, or another object that the person intends to use 31 for: 32 (1) introducing into the person's body a controlled substance; 33 (2) testing the strength, effectiveness, or purity of a controlled 34 substance; or 35 (3) enhancing the effect of a controlled substance; 36 commits a Class C misdemeanor. However, the offense is a Class A 37 misdemeanor if the person has a prior unrelated judgment or conviction 38 under this section. 39 SECTION 14. IC 35-48-4-8.5, AS AMENDED BY P.L.153-2018, 40 SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 41 JULY 1, 2024]: Sec. 8.5. (a) A person who keeps for sale, offers for 42 sale, delivers, or finances the delivery of a raw material, an instrument, 2024 IN 99—LS 6236/DI 106 44 1 a device, or other object that is intended to be or that is designed or 2 marketed to be used primarily for: 3 (1) ingesting, inhaling, or otherwise introducing into the human 4 body marijuana, hash oil, hashish, salvia, a synthetic drug, or a 5 controlled substance; 6 (2) testing the strength, effectiveness, or purity of marijuana, hash 7 oil, hashish, salvia, a synthetic drug, or a controlled substance; 8 (3) enhancing the effect of a controlled substance; 9 (4) manufacturing, compounding, converting, producing, 10 processing, or preparing marijuana, hash oil, hashish, salvia, a 11 synthetic drug, or a controlled substance; 12 (5) diluting or adulterating marijuana, hash oil, hashish, salvia, a 13 synthetic drug, or a controlled substance by individuals; or 14 (6) any purpose announced or described by the seller that is in 15 violation of this chapter; 16 commits a Class A infraction for dealing in paraphernalia. 17 (b) A person who knowingly or intentionally violates subsection (a) 18 commits a Class A misdemeanor. However, the offense is a Level 6 19 felony if the person has a prior unrelated judgment or conviction under 20 this section. 21 (c) This section does not apply to the following: 22 (1) Items marketed for use in the preparation, compounding, 23 packaging, labeling, or other use of marijuana, hash oil, hashish, 24 salvia, a synthetic drug, or a controlled substance as an incident 25 to lawful research, teaching, or chemical analysis and not for sale. 26 (2) Items marketed for or historically and customarily used in 27 connection with the planting, propagating, cultivating, growing, 28 harvesting, manufacturing, compounding, converting, producing, 29 processing, preparing, testing, analyzing, packaging, repackaging, 30 storing, containing, concealing, injecting, ingesting, or inhaling 31 of tobacco or any other lawful substance. 32 (3) A qualified entity (as defined in IC 16-41-7.5-3) that provides 33 a syringe or needle as part of a program under IC 16-41-7.5. 34 (4) Any entity or person that provides funding to a qualified entity 35 (as defined in IC 16-41-7.5-3) to operate a program described in 36 IC 16-41-7.5. 37 (5) A person, including an adult cannabis user, patient, 38 caregiver, cannabis organization, research facility, or 39 transporter described in IC 7.1-8, if the person is in 40 substantial compliance with the requirements of IC 7.1-8. 41 SECTION 15. IC 35-48-4-10, AS AMENDED BY P.L.153-2018, 42 SECTION 25, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 2024 IN 99—LS 6236/DI 106 45 1 JULY 1, 2024]: Sec. 10. (a) A person who: 2 (1) knowingly or intentionally: 3 (A) manufactures; 4 (B) finances the manufacture of; 5 (C) delivers; or 6 (D) finances the delivery of; 7 marijuana, hash oil, hashish, or salvia, pure or adulterated; or 8 (2) possesses, with intent to: 9 (A) manufacture; 10 (B) finance the manufacture of; 11 (C) deliver; or 12 (D) finance the delivery of; 13 marijuana, hash oil, hashish, or salvia, pure or adulterated; 14 commits dealing in marijuana, hash oil, hashish, or salvia, a Class A 15 misdemeanor, except as provided in subsections (b) through (d). 16 (b) A person may be convicted of an offense under subsection (a)(2) 17 only if: 18 (1) there is evidence in addition to the weight of the drug that the 19 person intended to manufacture, finance the manufacture of, 20 deliver, or finance the delivery of the drug; or 21 (2) the amount of the drug involved is at least: 22 (A) ten (10) pounds, if the drug is marijuana; or 23 (B) three hundred (300) grams, if the drug is hash oil, hashish, 24 or salvia. 25 (c) The offense is a Level 6 felony if: 26 (1) the person has a prior conviction for a drug offense and the 27 amount of the drug involved is: 28 (A) less than thirty (30) grams of marijuana; or 29 (B) less than five (5) grams of hash oil, hashish, or salvia; or 30 (2) the amount of the drug involved is: 31 (A) at least thirty (30) grams but less than ten (10) pounds of 32 marijuana; or 33 (B) at least five (5) grams but less than three hundred (300) 34 grams of hash oil, hashish, or salvia. 35 (d) The offense is a Level 5 felony if: 36 (1) the person has a prior conviction for a drug dealing offense 37 and the amount of the drug involved is: 38 (A) at least thirty (30) grams but less than ten (10) pounds of 39 marijuana; or 40 (B) at least five (5) grams but less than three hundred (300) 41 grams of hash oil, hashish, or salvia; 42 (2) the: 2024 IN 99—LS 6236/DI 106 46 1 (A) amount of the drug involved is: 2 (i) at least ten (10) pounds of marijuana; or 3 (ii) at least three hundred (300) grams of hash oil, hashish, 4 or salvia; or 5 (B) offense involved a sale to a minor; or 6 (3) the: 7 (A) person is a retailer; 8 (B) marijuana, hash oil, hashish, or salvia is packaged in a 9 manner that appears to be low THC hemp extract; and 10 (C) person knew or reasonably should have known that the 11 product was marijuana, hash oil, hashish, or salvia. 12 (e) This section does not apply to a person, including an adult 13 cannabis user, patient, caregiver, cannabis organization, research 14 facility, or transporter described in IC 7.1-8, if the person is in 15 substantial compliance with the requirements of IC 7.1-8. 16 SECTION 16. IC 35-48-4-11, AS AMENDED BY P.L.153-2018, 17 SECTION 26, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE 18 JULY 1, 2024]: Sec. 11. (a) A person who: 19 (1) knowingly or intentionally possesses (pure or adulterated) 20 marijuana, hash oil, hashish, or salvia; 21 (2) knowingly or intentionally grows or cultivates marijuana; or 22 (3) knowing that marijuana is growing on the person's premises, 23 fails to destroy the marijuana plants; 24 commits possession of marijuana, hash oil, hashish, or salvia, a Class 25 B misdemeanor, except as provided in subsections (b) through (c). 26 (b) The offense described in subsection (a) is a Class A 27 misdemeanor if: 28 (1) the person has a prior conviction for a drug offense; or 29 (2) the: 30 (A) marijuana, hash oil, hashish, or salvia is packaged in a 31 manner that appears to be low THC hemp extract; and 32 (B) person knew or reasonably should have known that the 33 product was marijuana, hash oil, hashish, or salvia. 34 (c) The offense described in subsection (a) is a Level 6 felony if: 35 (1) the person has a prior conviction for a drug offense; and 36 (2) the person possesses: 37 (A) at least thirty (30) grams of marijuana; or 38 (B) at least five (5) grams of hash oil, hashish, or salvia. 39 (d) This section does not apply to a person, including an adult 40 cannabis user, patient, caregiver, cannabis organization, research 41 facility, or transporter described in IC 7.1-8, if the person is in 42 substantial compliance with the requirements of IC 7.1-8. 2024 IN 99—LS 6236/DI 106